Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
Tweet
Share
E-mailGet Alerts SPPI Hot Sheet
Price: $1.03 --0%
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 39
Rating Summary:
3 Buy, 6 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 39
Join SI Premium – FREE
Roth Capital downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Buy to Neutral with a price target of $9.00.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.13 yesterday.
For more ratings news on Spectrum Pharmaceuticals click here and for the rating history of Spectrum Pharmaceuticals click here.
Shares of Spectrum Pharmaceuticals closed at $8.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Healthpeak Properties Inc (DOC) to Equalweight Citing Limited Upside for the Call
- Guggenheim Downgrades Benitec BioPharma (BNTC) to Neutral
- Guggenheim Downgrades Passage Bio Inc. (PASG) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
